Skip to Content

ResMed posts double-digit increases

ResMed posts double-digit increases

SAN DIEGO – ResMed reported revenue of $894.9 million for the second quarter of fiscal year 2022, a 12% increase compared to the same period the prior year. 

It reported net income of $201.8 million, also a 12% increase. 

“Our second-quarter results reflect continued strong performance across our business resulting in double-digit top-line revenue growth, driven by ongoing high demand for our sleep and respiratory care products, and solid growth in our software-as-a-service business,” said Mick Farrell, ResMed CEO. “Our global ResMed team continues to find ways to deliver products and solutions to our customers, even amid ongoing supply chain challenges that have limited additional access to critical electronic components. We are working every day to meet the extraordinary demand generated by our competitor’s ongoing device recall. We continue to ensure priority for the highest-need patients first, and we are working with physicians, providers and healthcare systems to maintain delivery of medical devices and digital health solutions for the patients who need care.” 

ResMed reported revenue in the U.S., Canada and Latin America, excluding Software as a Service, increased 14%. It reported revenue for SaaS increased 8%, driven by growth in the DME category and stabilizing patient flow in out-of-hospital settings.


To comment on this post, please log in to your account or set up an account now.